RE: Accustem7 Feb 2022 09:09
When the Accustem was issued via a demerger some of the base cost of the Tils was to be apportioned to the Accustem line. To work out the apportionment factors you need to know the market value of each line at the point of the Demerger. The company do not reply to emails, the registrar are denying all knowledge. I'm now trying to track down the ADR's and when they will be issued. I don't understand how a company can treat their shareholders like this